Results 31 to 40 of about 25,658,089 (295)

On the viability of Escherichia coli cells lacking DNA topoisomerase I [PDF]

open access: yes, 2012
Copyright @ 2012 Stockum et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution,
Lloyd, RG   +8 more
core   +1 more source

A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas

open access: yesFrontiers in Oncology, 2022
Topoisomerases, targets of inhibitors used in chemotherapy, induce DNA breaks accumulation leading to cancer cell death. A newly synthesized copper(II) indenoisoquinoline complex WN197 exhibits a cytotoxic effect below 0.5 µM, on MDA-MB-231, HeLa, and HT-
Caroline Molinaro   +6 more
doaj   +1 more source

The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA [PDF]

open access: yes, 2011
<b>Background</b> Type II DNA topoisomerases are essential, ubiquitous enzymes that act to relieve topological problems arising in DNA from normal cellular activity.
Caroline A. Austin   +7 more
core   +2 more sources

Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.

open access: yesPLoS ONE, 2014
DNA topoisomerases are enzymes responsible for the relaxation of DNA torsional strain, as well as for the untangling of DNA duplexes after replication, and are important cancer drug targets.
Malgorzata N Drwal   +5 more
doaj   +1 more source

Structures of representative HDAC and topoisomerase I inhibitors.

open access: yes, 2018
Structures of representative HDAC and topoisomerase I inhibitors.
Raffaella Cincinelli (192154)   +12 more
core   +1 more source

Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases [PDF]

open access: yes, 2010
ype II DNA topoisomerases are ubiquitous enzymes with essential functions in DNA replication, recombination and transcription. They change DNA topology by forming a transient covalent cleavage complex with a gate-DNA duplex that allows transport of a ...
Laponogov, I   +27 more
core   +1 more source

Recent Developments in Combination Chemotherapy for Colorectal and Breast Cancers with Topoisomerase Inhibitors

open access: yes, 2023
DNA topoisomerases are important enzymes that stabilize DNA supercoiling and resolve entanglements. There are two main types of topoisomerases in all cells: type I, which causes single-stranded DNA breaks, and type II, which cuts double-stranded DNA ...
Nam Deuk Kim   +2 more
core   +1 more source

Inhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer Therapy

open access: yesBiomolecules, 2015
Most chemotherapy regimens contain at least one DNA-damaging agent that preferentially affects the growth of cancer cells. This strategy takes advantage of the differences in cell proliferation between normal and cancer cells.
Yang Xu, Chengtao Her
doaj   +1 more source

Iridoids as DNA topoisomerase I poisons [PDF]

open access: yes, 2005
The discovery of new topoisomerase I inhibitors is necessary since most of the antitumor drugs are targeted against type II and only a very few can specifically affect type I.
Gálvez, Marina   +2 more
core   +1 more source

Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents. [PDF]

open access: yesPLoS ONE, 2018
Recent studies have shown that HDAC inhibitors act synergistically with camptothecin derivatives in combination therapies. To exploit this synergy, new hybrid molecules targeting simultaneously topoisomerase I and HDAC were designed.
Raffaella Cincinelli   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy